Watch On Demand!
Clinical trial data and real-world data (RWD) have historically existed in separate data silos, limiting study investigators’ ability to understand what is happening to participating patient cohorts beyond the clinical trial.
During COVID, we learned how federal health agencies could leverage Privacy-Preserving Record Linkage (PPRL) technology to converge data and accelerate the path to COVID vaccines and treatments. We will share insights as to how life sciences leaders are incorporating these lessons into clinical trial processes to expand their patient insights beyond the constraints of the clinical trial.
Featured Topics include:
- Explore the benefits of accurately linking primary and RWD data, including lowering patient and investigator burden, maintaining visibility during trial, enabling sub-cohort analysis and safety contextualization, and supporting evidence generation
- Understand factors the FDA considers when assessing RWD and its use in a submission or to support other regulatory requirements
- Learn from key case studies about how government and life science leaders are adopting this innovative approach within their organizations
|Sandra Leonard, MPH Healthcare Planning and Administration, Senior Vice President, Partnerships and Real-World Data Solutions, HealthVerity|